Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The purpose of this study is to evaluate the efficacy of neoadjuvant immunoradiotherapy (NIRT) prior to surgery for the treatment of stage III and IVA HPV- HNSCC.
Epistemonikos ID: 036b180556b61ecd35f3091f87290ab298e016bc
First added on: May 09, 2024